具有抗癌治疗潜力的1,2,3-triazole杂交物的当前景观:第一部分
Shanshan Huang1, Zhi Xu2, Yafei Zhuang3
1School of Chemistry and Pharmaceutical Engineering, Huanghuai University, Zhumadian, Henan, China.
新的1,2,3-triazole混合物显示出作为抗癌化疗药物的前景. 这些化合物提供了多目标机制来克服耐药性并减少癌症治疗中的副作用.
科学领域:
- 药用化学 医学化学
- 有机化学 有机化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 癌症是一个重大的全球健康挑战,发病率和死亡率不断增加.
- 目前的化疗药物由于多药耐药性和严重的副作用而面临限制.
- 迫切需要新的抗癌药物来改善患者的治疗结果.
研究的目的:
- 审查1,2,3-triazole杂交物的抗癌治疗潜力.
- 探索它们的作用机制,设计原则和结构-活动关系 (SARs).
- 突出该领域最近 (2021年以后) 的进展.
主要方法:
- 从2021年起发表的科学文章的文献综述.
- 对研究的分析,重点关注具有抗癌活性的1,2,3-triazole杂交物.
- 结构-活动关系 (SARs) 的综合和评估.
主要成果:
- 1,2,3-三醇是开发创新的抗癌药物的特权支架.
- 1,2,3-三醇混合物表现出针对癌症进展的多目标机制.
- 几种1,2,3-triazole杂交物已被批准或在临床试验中用于癌症治疗.
结论:
- 1,2,3-三醇杂交物是癌症治疗中有价值的一类化合物.
- 他们的多目标方法可以克服抵抗力并减轻副作用.
- 对1,2,3-triazole杂交物的进一步研究具有显著的治疗前景.
更多相关视频
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
07:20Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
